Showing results (941-950 of 968) with videos related to

Sort By:
Pageof 97
Journal for Immunotherapy of Cancer|June 9, 2022
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of responseRobert B Rebhun, Daniel York, Sylvia Margret Cruz, et al.
American Journal of Human Genetics|January 13, 2022
The genetic architecture of pediatric cardiomyopathyStephanie M Ware, Surbhi Bhatnagar, Phillip J Dexheimer, et al.
Circulation|March 30, 2013
Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US childrenChristopher S Almond, David L Morales, Eugene H Blackstone, et al.
American Heart Journal|June 14, 2023
Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathySonya Kirmani, Pamela K Woodard, Ling Shi, et al.
Science Translational Medicine|November 26, 2020
Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantationLam T Khuat, Catherine T Le, Chien-Chun Steven Pai, et al.
Circulation. Heart Failure|May 9, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical TrialConstantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja, et al.
Journal of the American Heart Association|April 28, 2021
Genetic Causes of Cardiomyopathy in Children: First Results From the Pediatric Cardiomyopathy Genes StudyStephanie M Ware, James D Wilkinson, Muhammad Tariq, et al.
Frontiers in Immunology|November 10, 2025
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcomaRobert B Rebhun, Sylvia M Cruz, Daniel York, et al.
American Heart Journal|September 19, 2024
Rationale and design of CHD PULSE: Congenital Heart Disease Project to Understand Lifelong Survivor ExperienceMatthew E Oster, Yanxu Yang, Caroline Shi, et al.
Eclinicalmedicine|August 3, 2023
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group studyGuy de Bruyn, Joyce Wang, Annie Purvis, et al.
Pageof 97